1. Home
  2. Labeler Index
  3. Merck Sharp & Dohme Corp.
  4. 0006-4084
  5. NDC Package Code: 0006-4084-00 Antivenin

NDC Package 0006-4084-00 Antivenin

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0006-4084-00
Package Description:
1 KIT in 1 CARTON * 1 mL in 1 VIAL (0006-9011-00) * 2.5 mL in 1 VIAL (0006-9002-00) * 2.5 mL in 1 VIAL
Product Code:
0006-4084
Proprietary Name:
Antivenin
Usage Information:
Antivenin (Latrodectus mactans) is used to treat patients with symptoms due to bites by the black widow spider (Latrodectus mactans). Early use of the Antivenin is emphasized for prompt relief.Local muscular cramps begin from 15 minutes to several hours after the bite which usually produces a sharp pain similar to that caused by puncture with a needle. The exact sequence of symptoms depends somewhat on the location of the bite. The venom acts on the myoneural junctions or on the nerve endings, causing an ascending motor paralysis or destruction of the peripheral nerve endings. The groups of muscles most frequently affected at first are those of the thigh, shoulder, and back. After a varying length of time, the pain becomes more severe, spreading to the abdomen, and weakness and tremor usually develop. The abdominal muscles assume a boardlike rigidity, but tenderness is slight. Respiration is thoracic. The patient is restless and anxious. Feeble pulse, cold, clammy skin, labored breathing and speech, light stupor, and delirium may occur. Convulsions also may occur, particularly in small children. The temperature may be normal or slightly elevated. Urinary retention, shock, cyanosis, nausea and vomiting, insomnia, and cold sweats also have been reported. The syndrome following the bite of the black widow spider may be confused easily with any medical or surgical condition with acute abdominal symptoms.The symptoms of black widow spider bite increase in severity for several hours, perhaps a day, and then very slowly become less severe, gradually passing off in the course of two or three days except in fatal cases. Residual symptoms such as general weakness, tingling, nervousness, and transient muscle spasm may persist for weeks or months after recovery from the acute stage.If possible, the patient should be hospitalized. Other additional measures giving greatest relief are prolonged warm baths and intravenous injection of 10 mL of 10 percent solution of calcium gluconate repeated as necessary to control muscle pain. Morphine also may be required to control pain. Barbiturates may be used for extreme restlessness. However, as the venom is a neurotoxin, it can cause respiratory paralysis. This must be borne in mind when considering use of morphine or a barbiturate. Adrenocorticosteroids have been used with varying degrees of success. Supportive therapy is indicated by the condition of the patient. Local treatment of the site of the bite is of no value. Nothing is gained by applying a tourniquet or by attempting to remove venom from the site of the bite by incision and suction.In otherwise healthy individuals between the ages of 16 and 60, the use of Antivenin may be deferred and treatment with muscle relaxants may be considered.
11-Digit NDC Billing Format:
00006408400
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Labeler Name:
Merck Sharp & Dohme Corp.
Sample Package:
No
FDA Application Number:
BLA101062
Marketing Category:
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date:
05-14-1947
End Marketing Date:
03-27-2015
Listing Expiration Date:
03-27-2015
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 0006-4084-00?

The NDC Packaged Code 0006-4084-00 is assigned to a package of 1 kit in 1 carton * 1 ml in 1 vial (0006-9011-00) * 2.5 ml in 1 vial (0006-9002-00) * 2.5 ml in 1 vial of Antivenin, labeled by Merck Sharp & Dohme Corp.. The product's dosage form is and is administered via form.

Is NDC 0006-4084 included in the NDC Directory?

No, Antivenin with product code 0006-4084 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Merck Sharp & Dohme Corp. on May 14, 1947 and its listing in the NDC Directory is set to expire on March 27, 2015 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 0006-4084-00?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units.

What is the 11-digit format for NDC 0006-4084-00?

The 11-digit format is 00006408400. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
4-4-20006-4084-005-4-200006-4084-00